Description: * PT-141 (Bremelanotide) is a unique synthetic peptide developed to evaluate and modulate central neurological pathways tied to sexual arousal and libido.
Unlike traditional vascular compounds, PT-141 completely bypasses the cardiovascular system, acting directly as a non-selective agonist on central melanocortin receptors (MC3R and MC4R).
Clinical research shows major efficacy in treating erectile dysfunction models in males and hypoactive sexual desire disorders (HSDD) within female test subjects.
Furthermore, its interaction with dopamine pathways indicates potential benefits in uplifting depressive baselines and lowering stress-induced performance anxiety.
An essential compound for neuro-endocrinological studies focusing on intimacy dysfunction, behavioral psychology, and central nervous system modulation.
Reviews
There are no reviews yet.